We take a deeper look at what it is, what it promises, and what to know

Often positioned as the next frontier in personalised health, peptide therapy has quickly emerged as one of the most talked-about developments in modern wellness. Promising everything from improved recovery and metabolic balance to enhanced skin quality and sustained energy. But beyond the headlines, what exactly are peptides, and how much of this growing interest is grounded in evidence?

Unlike traditional medication, peptide therapy is not about introducing something foreign to the body, but rather working with its existing systems. “Peptide therapy is essentially a way of using the body’s own communication system to improve how it functions,” explains Dr Anant Vinjamoori, Chief Medical Officer at Valeo Health.

Peptides themselves are short chains of amino acids, the same building blocks that form proteins, but their role is distinct. Rather than acting as structure, they act as signals. “They send instructions between cells, telling the body to do things like repair tissue, regulate hormones, or reduce inflammation,” he says. Over time, these signalling pathways naturally decline, and peptide therapy aims to restore or enhance them with targeted precision.

 “They are designed to target very specific pathways in the body,” Dr Vinjamoori explains. Unlike traditional medications, which often affect multiple systems at once, peptides act more like direct instructions, influencing individual biological processes rather than broadly altering physiology. It’s this precision that has positioned peptides at the forefront of a wider shift towards more tailored, data-driven wellness. 

Why Now?

The surge in interest surrounding peptide therapy reflects a convergence of cultural and scientific shifts “It has gained widespread attention largely because of the rise of longevity-focused wellness and the mainstream success of drugs like semaglutide,” says Dr. Vinjamoori. At the same time, the conversation around health has evolved. Increasingly, the focus is not on treating illness, but on addressing early signs of decline, subtle changes in energy, recovery, sleep and metabolism that fall outside the scope of traditional medicine. “Most people exploring peptide therapy are not treating illness, but rather addressing subtle signs of decline,” he notes.

Where Peptides Make a Difference

While still an evolving field, peptide therapy is most commonly associated with areas closely tied to cellular signalling and repair. Anti-ageing remains one of the most visible applications, particularly through peptides that support collagen production and skin health.

Beyond aesthetics, “there is growing interest in metabolic health, particularly around appetite regulation and blood sugar control,” says Dr Vinjamoori. Other areas include sleep, cognitive function and physical recovery, reflecting the central role peptides play in regulating the body’s internal systems.

Certain categories have become especially prominent. GLP-1 receptor agonists, such as semaglutide and tirzepatide, are widely recognised for their impact on weight management and metabolic health. Elsewhere, growth hormone–supporting peptides like CJC-1295 and Ipamorelin are often associated with improved recovery, sleep and body composition.

Peptides linked to tissue repair, such as BPC-157, are also gaining attention, particularly in the context of injury and inflammation. Their appeal lies in their ability to target processes that naturally decline with age or stress, offering a more directed approach to maintaining performance.

One of the defining characteristics of peptide therapy is its gradual nature. “Results from peptide therapy tend to build rather than appear instantly,” Dr. Vinjamoori explains.

Early changes, such as improved sleep or appetite regulation, may emerge within weeks, while more visible or structural shifts, including skin quality or body composition, typically take longer. 

A More Personal Approach to Health

What peptide therapy ultimately represents is a broader shift in how health is approached. Moving away from reactive treatment models, it reflects a growing emphasis on prevention, optimisation and personalisation. Looking ahead, the field is expected to become more refined. “Over the next decade, peptide therapy is likely to become more evidence-driven,” says Dr Vinjamoori. As clinical data expands and regulation strengthens, its role may evolve from a trend-led category into a more integrated part of preventative care.